A new tool to assess Clinical Diversity In Meta‐analyses (CDIM) of interventions

Autor: Barbateskovic, Marija ^{a, b, ⁎}, Koster, Thijs M. ^c, Eck, Ruben J. ^d, Maagaard, Mathias ^a, Afshari, Arash ^e, Blokzijl, Fredrike ^f, Cronhjort, Maria ^g, Dieperink, Willem ^c, Fabritius, Maria L. ^h, Feinberg, Josh ⁱ, French, Craig ^j, Gareb, Barzi ^k, Geisler, Anja ^l, Granholm, Anders ^m, Hiemstra, Bart ⁿ, Hu, Ruixue ^o, Imberger, Georgina ^p, Jensen, Bente T. ^q, Jonsson, Andreas B. ^m, Karam, Oliver ^r, Kong, De Zhao ^{s, t}, Korang, Steven K. ^a, Koster, Geert ^c, Lai, Baoyong ^u, Liang, Ning ^v, Lundstrøm, Lars H. ^w, Marker, Søren ^{b, m}, Meyhoff, Tine S. ^{b, m}, Nielsen, Emil E. ⁱ, Nørskov, Anders K. ^a, Munch, Marie W. ^m, Risom, Emilie C. ^x, Rygård, Sofie L. ^m, Safi, Sanam ^a, Sethi, Naqash ^a, Sjövall, Fredrik ^y, Lauridsen, Susanne V. ^{z, aa}, van Bakelen, Nico ^k, Volbeda, Meint ^c, van der Horst, Iwan C.C. ^bb, Gluud, Christian ^a, Perner, Anders ^{b, m}, Møller, Morten H. ^{b, m}, Keus, Eric ^c, Wetterslev, Jørn ^{a, b}

Publikováno v: In Journal of Clinical Epidemiology July 2021 135:29-41

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

sj-pdf-1-tan-10.1177_17562864221090398 – Supplemental material for Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE

Autor: Hupperts, Raymond, Gasperini, Claudio, Lycke, Jan, Ziemssen, Tjalf, Feys, Peter, Xiao, Shan, Acosta, Carlos, Koster, Thijs, Hobart, Jeremy

Supplemental material, sj-pdf-1-tan-10.1177_17562864221090398 for Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bce050e7e4ce9790766ef2a9914b5d

Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.

Autor: Salvetti M; Department of Neurosciences, Mental Health and Sensory Organs, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy; IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Molise, Italy., Wray S; Hope Neurology MS Center, Knoxville, TN, USA., Nelles G; NeuroMed Campus Hohenlind, Cologne, Germany., Belviso N; Biogen Inc, Cambridge, MA, USA., Kumar A; Biogen Inc, Badhoevedorp, the Netherlands., Koster T; Biogen Inc, Cambridge, MA, USA., Castro-Borrero W; Biogen Inc, Cambridge, MA, USA., Vignos M; Biogen Inc, Cambridge, MA, USA.

Publikováno v: Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2024 May 23; Vol. 10 (2), pp. 20552173241238632. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).